Bhagat, Davis Kirby, Breanne Bhatt, Harit Jager, Rama George, Meena Sheth, Veeral
Published in
Clinical Ophthalmology (Auckland, N.Z.)
Purpose To evaluate treatment-related preferences among patients receiving intravitreal anti-vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME). Patients and Methods We conducted a prospective survey of patients with nAMD or DME treated at one of three US-based r...
Lestable, L Gabrielle, P H Bron, A M Nguyen, P Creuzot-Garcher, C
Published in
Journal francais d'ophtalmologie
To describe the one-year functional outcomes of treatment-naïve neovascular age-related macular degeneration (nAMD) treated with anti-VEGF agents at the Dijon University Hospital Ophthalmology Department. Real-life interventional study including all treatment-naïve nAMD patients from January 2016 to December 2018 in the Ophthalmology Department of ...
Holz, Frank G Figueroa, Marta S Bandello, Francesco Yang, Yit Ohji, Masahito Dai, Hong Wykrota, Halina Sharma, Sanjay Dunger-Baldauf, Cornelia Lacey, Sue
...
Published in
Retina (Philadelphia, Pa.)
To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in treatment-naive patients with neovascular age-related macular degeneration enrolled in LUMINOUS study. This 5-year, prospective, multicenter, observational study recruited 30,138 adult patients (treatment-naive or previously treated with ranibizumab or other ocul...
Moraru, Andreea Dana Costin, Dănuț Moraru, Radu Lucian Costuleanu, Marcel Brănișteanu, Daniel Constantin
Published in
Experimental and Therapeutic Medicine
This review presents a systematic analysis of the literature regarding the pachychoroid disease spectrum nomenclature, diagnosis criteria and therapeutic options. Pachychoroid related diseases are a new concept, introduced into the ophthalmological nomenclature in 2013 and evolving both as concept and as classification since then. The six disorders...
Veluswamy, Balaji Lee, Andy Mirza, Rukhsana G Gill, Manjot K
Published in
Clinical ophthalmology (Auckland, N.Z.)
Neovascular age-related macular degeneration (nv-AMD) is the leading cause of blindness in individuals 55 years and older. The advent of anti-vascular endothelial growth factor (anti-VEGF) therapy has greatly altered the visual acuity (VA) prognosis in these patients. While many studies have described treatment outcomes, few have explored the impac...
Farinha, Cláudia Santos, Torcato Santos, Ana Rita Lopes, Marta Alves, Dalila Silva, Rufino Cunha-Vaz, José
Published in
Retina (Philadelphia, Pa.)
To test optical coherence tomography leakage in the identification and quantification of choroidal neovascularization-related fluid, its change after anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration eyes and its relation to functional outcome. Prospective analysis of a cohort of neovascular age-related...
Lisi, Lucia Chiavari, Marta Ciotti, Gabriella Maria Pia Lacal, Pedro M Navarra, Pierluigi Graziani, Grazia
Published in
Expert opinion on drug metabolism & toxicology
Introduction: The worldwide incidence of central nervous system (CNS) primary tumors is increasing. Most of the chemotherapeutic agents used for treating these cancer types induce DNA damage, and their activity is affected by the functional status of repair systems involved in the detection or correction of DNA lesions. Unfortunately, treatment of ...
Lang, Gabriele E Stahl, Andreas Voegeler, Jessica Quiering, Claudia Lorenz, Katrin Spital, Georg Liakopoulos, Sandra
Published in
Acta ophthalmologica
Panretinal photocoagulation (PRP) is the current standard of care in proliferative diabetic retinopathy (PDR). However, treatment with anti-vascular endothelial growth factor agents might offer better patient outcomes with fewer side-effects. The PRIDE study aimed to assess the efficacy and safety of ranibizumab with or without PRP compared with PR...
Meng, Qingyu Cheng, Yong Wu, Xi Zhao, Dan Zhao, Mingwei Liang, Jianhong
Published in
Clinical & experimental optometry
To evaluate the refractive outcomes in children treated with intravitreal injection of ranibizumab (IVR) for retinopathy of prematurity (ROP). A retrospective study of 95 patients (186 eyes) was conducted. All patients received IVR treatment. The cycloplegic refraction was evaluated at three months, six months, 12 months and 24 months. The average ...
Wu, Peipei Shi, Depeng Chen, Xiuli Feng, Chengcheng Xu, Haifeng Lin, Ping
Published in
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Purpose: To investigate the long-term efficacy of intravitreal conbercept injection in treating idiopathic choroidal neovascularization (CNV). Methods: In this longitudinal retrospective cohort study, 27 eyes (27 patients) with idiopathic CNV receiving conbercept intravitreously (0.5 mg/0.05 mL) with 1+PRN regimen were included. Best corrected visu...
